Probiotic Intervention for Occasional Constipation

Probi AB

Status

Completed

Conditions

Occasional Constipation

Gut Function

Treatments

Dietary Supplement: Probiotics

Dietary Supplement: Placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT06444139

23PICPP01

Details and patient eligibility

About

The goal of this clinical trial is to study the effect of probiotics on gut function in subjects with occasional constipation. The main question it aim to answer is if intake of probiotics will decrease the transit time. Participants will randomized to either consume probiotics or a placebo product.

Enrollment

100 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Males and females aged 18 - 65 years
With occasional constipation
Agrees to maintain current lifestyle habits
Healthy
Provided voluntary, written, informed consent to participate in the study

Exclusion criteria

Individuals who are pregnant, breast feeding, or planning to become pregnant during the study
Allergy, sensitivity, or intolerance to study products or clinical assessment materials
Chronic constipation
Current or history of significant diseases or abnormalities of the gastrointestinal tract (examples (include but are not limited to atrophic gastritis, celiac disease, gluten intolerance/sensitivity, inflammatory bowel disease)
Unstable metabolic disease or chronic diseases
Unstable hypertension.
Type I or Type II diabetes, cancer
Significant cardiovascular event in the past 6 months. History of or current diagnosis with kidney and/or liver diseases
Self-reported confirmation of current or pre-existing thyroid condition.
Individuals with an autoimmune disease or are immune compromised
Self-reported confirmation of a HIV-, Hepatitis B- and/or C-positive diagnosis, blood/bleeding disorders
Any other condition or lifestyle factor, that may adversely affect the participant's ability to complete the study or its measures or pose significant risk to the participant